Pancreas Transplantation

• FDA approval · 2019-01-31
  FDA Approved: TACROLIMUS — Original Application (Accord Healthcare Inc.)

  The FDA approves Accord Healthcare Inc.'s Original Application for tacrolimus (generic tacrolimus) for prevention of organ transplant reject…

• FDA approval · 2018-11-29
  FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)

  The FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) from Astellas Pharma US, Inc., expanding/…

• FDA approval · 2012-02-06
  FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

  The FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., updating its label to cover transplant-r…

• FDA approval · 2009-02-13
  FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

  FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., indicating an approved change to the existin…